Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 EUCAST technical note on fluconazole.

× No keyword cloud information.

26 in total

Review 1. Progress in antifungal susceptibility testing of Candida spp. by use of Clinical and Laboratory Standards Institute broth microdilution methods, 2010 to 2012.

Authors: M A Pfaller; D J Diekema
Journal: J Clin Microbiol Date: 2012-06-27 Impact factor: 5.948

2. Recent exposure to caspofungin or fluconazole influences the epidemiology of candidemia: a prospective multicenter study involving 2,441 patients.

Authors: Olivier Lortholary; Marie Desnos-Ollivier; Karine Sitbon; Arnaud Fontanet; Stéphane Bretagne; Françoise Dromer
Journal: Antimicrob Agents Chemother Date: 2010-11-15 Impact factor: 5.191

3. Pharmacokinetics of Caspofungin in Critically Ill Patients in Relation to Liver Dysfunction: Differential Impact of Plasma Albumin and Bilirubin Levels.

Authors: S Kurland; M Furebring; E Löwdin; E Eliasson; E I Nielsen; J Sjölin
Journal: Antimicrob Agents Chemother Date: 2019-05-24 Impact factor: 5.191

4. Optimization of Fluconazole Dosing for the Prevention and Treatment of Invasive Candidiasis Based on the Pharmacokinetics of Fluconazole in Critically Ill Patients.

Authors: J M Boonstra; A G Märtson; I Sandaradura; J G W Kosterink; T S van der Werf; D J E Marriott; J G Zijlstra; D J Touw; J W C Alffenaar
Journal: Antimicrob Agents Chemother Date: 2021-02-17 Impact factor: 5.191

5. Frequency of voriconazole resistance in vitro among Spanish clinical isolates of Candida spp. According to breakpoints established by the Antifungal Subcommittee of the European Committee on Antimicrobial Susceptibility Testing.

Authors: M Cuenca-Estrella; A Gomez-Lopez; I Cuesta; O Zaragoza; E Mellado; J L Rodriguez-Tudela
Journal: Antimicrob Agents Chemother Date: 2011-01-31 Impact factor: 5.191

6. Prevalence of Candida dubliniensis fungemia in Argentina: identification by a novel multiplex PCR and comparison of different phenotypic methods.

Authors: Maria Eugenia Bosco-Borgeat; Constanza Giselle Taverna; Susana Cordoba; Maria Guillermina Isla; Omar Alejandro Murisengo; Wanda Szusz; Walter Vivot; Graciela Davel
Journal: Mycopathologia Date: 2011-07-13 Impact factor: 2.574

7. In Vitro Susceptibility Testing in Fungi: What is its Role in Clinical Practice?

Authors: Susanne Perkhofer; Cornelia Mrazek; Lukas Hartl; Cornelia Lass-Flörl
Journal: Curr Infect Dis Rep Date: 2010-11 Impact factor: 3.725

8. Comparison of the broth microdilution (BMD) method of the European Committee on Antimicrobial Susceptibility Testing with the 24-hour CLSI BMD method for testing susceptibility of Candida species to fluconazole, posaconazole, and voriconazole by use of epidemiological cutoff values.

Authors: M A Pfaller; A Espinel-Ingroff; L Boyken; R J Hollis; J Kroeger; S A Messer; S Tendolkar; D J Diekema
Journal: J Clin Microbiol Date: 2011-01-12 Impact factor: 5.948

9. Genetic dissection of azole resistance mechanisms in Candida albicans and their validation in a mouse model of disseminated infection.

Authors: Donna M MacCallum; Alix Coste; Françoise Ischer; Mette D Jacobsen; Frank C Odds; Dominique Sanglard
Journal: Antimicrob Agents Chemother Date: 2010-01-19 Impact factor: 5.191

10. Breakpoints for susceptibility testing should not divide wild-type distributions of important target species.

Authors: Maiken Cavling Arendrup; Gunnar Kahlmeter; Juan Luis Rodriguez-Tudela; J Peter Donnelly
Journal: Antimicrob Agents Chemother Date: 2009-02-02 Impact factor: 5.191